The EORTC QLQ-HDC29: A supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation

European Journal of Cancer

Volumn 43, Issue 1, 2007, Pages 87-94

  Velikova, G ^a   Weis, J ^b   Hjermstad, M J ^c   Kopp, M ^d   Morris, P ^e   Watson, M ^f   Sezer, O ^g  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b Tumour Biology Center   (Germany)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^e HAMMERSMITH HOSPITAL   (United Kingdom)

^f INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cancer; High dose chemotherapy; Oncology; Quality of life; Stem cell transplantation

Indexed keywords

ANTINEOPLASTIC AGENT;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRIA; CANCER CHEMOTHERAPY; DRUG MEGADOSE; DRY THROAT; DYSPHAGIA; FEMALE; GASTROINTESTINAL SYMPTOM; GERMANY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL LITERATURE; MOUTH PAIN; NORWAY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SEMI STRUCTURED INTERVIEW; SIDE EFFECT; SORE THROAT; TASTE; UNITED KINGDOM; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANXIETY; ATTITUDE OF HEALTH PERSONNEL; COMBINED MODALITY THERAPY; FEMALE; HEALTH STATUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; STATISTICS; STRESS, PSYCHOLOGICAL;

EID: 33845979481     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.09.004     Document Type: Article

References (31)

1. Gratwohl A., Baldomero H., Schmid O., Horisberger B., Bargetzi M., Urbano-Ispizua A., et al. Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003. Bone Marrow Transplant 36 7 (2005) 575-590
2. Cornelissen J.J., and Lowenberg B. Role of allogeneic stem cell transplantation in current treatment of acute myeloid leukemia. Hematology (Am Soc Hematol Educ Program) 151-155 (2005) 151-155
3. Gokbuget N., and Hoelzer D. Recent approaches in acute lymphoblastic leukemia in adults. Rev Clin Exp Hematol 6 2 (2002) 114-141
4. Attal M., Harousseau J.L., Stoppa A., et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. New Engl J Med 335 (1996) 91-97
5. Child J.A., Morgan G.J., Davies F.E., et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. New Engl J Med 348 19 (2003) 1875-1883
6. Schmitz N., Pfistner B., Sextro M., et al. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial. Lancet 359 9323 (2002) 2065-2071
7. Philip T., Guglielmi C., Hagenbeek A., et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. New Engl J Med 333 23 (1995) 1540-1545
8. Schmoll H.J., Souchon R., Krege S., et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 15 9 (2004) 1377-1399
9. Nitz U.A., Mohrmann S., Fischer J., et al. Comparison of rapidly cycled tandem high-dose chemotherapy plus peripheral-blood stem-cell support versus dose-dense conventional chemotherapy for adjuvant treatment of high-risk breast cancer: results of a multicentre phase III trial. Lancet 366 9501 (2005) 1935-1944
10. Schmitz N., Gratwohl A., and Goldman J.M. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders. Current practice in Europe in 1996 and proposals for an operational classification. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 17 4 (1996) 471-477
11. Beyer J., Schwella N., Zingsem J., et al. Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison. J Clin Oncol 13 6 (1995) 1328-1335
12. Neitzert C.S., Ritvo P., Dancey J., Weiser K., Murray C., Avery J., et al. The psychosocial impact of bone marrow transplantation: a review of the literature. Bone Marrow Transplant 22 5 (1998) 409-422
13. McQuellon R.P., Russell G.B., Cella D.F., et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant 19 4 (1997) 357-368
14. Heinonen H., Volin L., Uutela A., Zevon M., Barrick C., Ruutu T., et al. Quality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantation. Ann Hematol 80 3 (2001) 137-143
15. Hensel M., Egerer G., Schneeweiss A., Goldschmidt H., and Ho A.D. Quality of life and rehabilitation in social and professional life after autologous stem cell transplantation. Ann Oncol 3 2 (2002) 209-217
16. Worel N., Biener D., Kalhs P., et al. Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation. Bone Marrow Transplant 30 9 (2002) 619-626
17. Kopp M., Holzner B., Meraner V., et al. Quality of life in adult hematopoietic cell transplant patients at least 5 yr after treatment: a comparison with healthy controls. Eur J Haematol 74 4 (2005) 304-308
18. Syrjala K.L., Langer S.L., Abrams J.R., et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA 291 19 (2004) 2335-2343
19. Andrykowski M.A., Bishop M.M., Hahn E.A., et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol 23 3 (2005) 599-608
20. Andrykowski M.A., Bruehl S., Brady M.J., and Henslee-Downey P.J. Physical and psychosocial status of adults one-year after bone marrow transplantation: a prospective study. Bone Marrow Transplant 15 6 (1995) 837-844
21. McQuellon R.P., Russell G.B., Rambo T.D., et al. Quality of life and psychological distress of bone marrow transplant recipients: the 'time trajectory' to recovery over the first year. Bone Marrow Transplant 21 5 (1998) 477-486
22. Knobel H., Loge J.H., Nordoy T., et al. High level of fatigue in lymphoma patients treated with high-dose therapy. J Pain Symptom Manage 19 6 (2000) 446-456
23. Hjermstad M.J., Knobel H., Brinch L., et al. A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation. Bone Marrow Transplant 34 3 (2004) 257-266
24. Syrjala K.L., Dikmen S., Langer S.L., Roth-Roemer S., and Abrams J.R. Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant. Blood 104 10 (2004) 3386-3392
25. Van Dam F.S., Schagen S.B., Muller M.J., et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90 3 (1998) 210-218
26. Diez-Campelo M., Perez-Simon J.A., Gonzalez-Porras J.R., et al. Quality of life assessment in patients undergoing reduced intensity conditioning allogeneic as compared to autologous transplantation: results of a prospective study. Bone Marrow Transplant 34 8 (2004) 729-738
27. Brandberg Y., Michelson H., Nilsson B., et al. Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with Fluorouracil, epirubicin, and cyclophosphamide: Scandinavian Breast Group Study 9401. J Clin Oncol 21 19 (2003) 3659-3664
28. Watson M., Buck G., Wheatley K., et al. Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients; analysis of the UK Medical Research Council AML 10 Trial. Eur J Cancer 40 7 (2004) 971-978
29. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 5 (1993) 365-376
30. Sprangers M.A., Cull A., Bjordal K., Groenvold M., and Aaronson N.K. The European Organization for Research and Treatment of Cancer. Approach to quality of life assessment: guidelines for developing questionnaire modules. EORTC Study Group on Quality of Life. Qual Life Res 2 4 (1993) 287-295
31. Bottomley A., Vachalec S., Bjordal K., Blazeby J., Flechtner H., Ruyskart P., et al. The development and utilisation of the European Organisation for research and treatment of cancer quality of life group item bank. Eur J Cancer 38 12 (2002) 1611-1614